Udg Healthcare (LON:UDG)‘s stock had its “buy” rating reaffirmed by research analysts at Peel Hunt in a research note issued on Tuesday.
Other analysts have also recently issued reports about the company. Liberum Capital reissued a “buy” rating and set a GBX 884 ($11.40) target price on shares of Udg Healthcare in a research note on Wednesday, August 8th. Jefferies Financial Group raised Udg Healthcare to a “buy” rating and lowered their target price for the stock from GBX 895 ($11.55) to GBX 890 ($11.48) in a research note on Thursday, August 9th. Barclays started coverage on Udg Healthcare in a research note on Thursday, May 17th. They set an “equal weight” rating and a GBX 875 ($11.29) target price for the company. Berenberg Bank increased their target price on Udg Healthcare from GBX 815 ($10.51) to GBX 850 ($10.96) and gave the stock a “hold” rating in a research note on Wednesday, June 6th. Finally, Numis Securities reissued a “reduce” rating on shares of Udg Healthcare in a research note on Wednesday, August 8th. One analyst has rated the stock with a sell rating, four have assigned a hold rating and four have given a buy rating to the stock. Udg Healthcare currently has an average rating of “Hold” and an average target price of GBX 850.67 ($10.97).
LON UDG opened at GBX 684.50 ($8.83) on Tuesday. Udg Healthcare has a 52-week low of GBX 690 ($8.90) and a 52-week high of GBX 963 ($12.42).
In other news, insider Chris Corbin sold 250,000 shares of the firm’s stock in a transaction that occurred on Thursday, June 14th. The shares were sold at an average price of GBX 900 ($11.61), for a total transaction of £2,250,000 ($2,902,476.78).
About Udg Healthcare
UDG Healthcare plc, together with its subsidiaries, provides advisory, communication, commercial, clinical, and packaging services to the healthcare industry in the Republic of Ireland, the United Kingdom, North America, and internationally. The company operates through three segments: Ashfield, Sharp, and Aquilant.
Featured Story: Marijuana Stocks Investing Considerations
Receive News & Ratings for Udg Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Udg Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.